戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  point-of-care assay as a screening tool for active pulmonary tuberculosis.
2 nchoalveolar lavage cells from patients with active pulmonary tuberculosis.
3 vation occur at extrapulmonary sites without active pulmonary tuberculosis.
4 t M. tuberculosis infection will progress to active pulmonary tuberculosis.
5 ncreased in BAL cells from involved sites of active pulmonary tuberculosis.
6  lavage from involved sites in patients with active pulmonary tuberculosis.
7 ion was made of not isolating a patient with active pulmonary tuberculosis.
8 pted to analyze these cells in patients with active pulmonary tuberculosis.
9                         Of 354 patients with active pulmonary tuberculosis, 274 successfully complete
10 s a major risk factor for the development of active pulmonary tuberculosis, although the immunologica
11 e cohort study of HIV-infected patients with active pulmonary tuberculosis and baseline CD4 counts </
12 pha in bronchoalveolar lavage (BAL) cells in active pulmonary tuberculosis, and evaluated the mechani
13 y household contacts (HHCs) of patients with active pulmonary tuberculosis are exposed aerogenically
14 B) generated from the cough of patients with active pulmonary tuberculosis are the source of MTB infe
15                  A substantial proportion of active pulmonary tuberculosis cases in countries where t
16 horts were household contacts of adults with active pulmonary tuberculosis disease.
17 In contrast, the cellular immune response in active pulmonary tuberculosis disrupts this innate immun
18 patients with primary and secondary cases of active pulmonary tuberculosis from the southern region (
19 e cohort of reported patients with suspected active pulmonary tuberculosis in 2008-2010 from Georgia,
20             Placing inpatients with presumed active pulmonary tuberculosis in respiratory isolation p
21 d datasets that examined clinical cohorts of active pulmonary tuberculosis infection in whole blood.
22 patitis C, human immunodeficiency virus, and active pulmonary tuberculosis is considered.
23                                              Active pulmonary tuberculosis is difficult to diagnose a
24                      Eight participants with active pulmonary tuberculosis (mean age, 48.1 years; age
25 ng all culture-positive patients treated for active pulmonary tuberculosis (n = 372) in San Francisco
26  mononuclear cells (PBMC) from patients with active pulmonary tuberculosis (n=16) and healthy subject
27 SPOT.TB (T-SPOT) among adults with suspected active pulmonary tuberculosis or patients with confirmed
28                                           In active pulmonary tuberculosis (PTB), the ratio of cortis
29 ammadelta T cells of patients diagnosed with active pulmonary tuberculosis showed that compared with
30                                          All active pulmonary tuberculosis (TB) cases newly diagnosed
31 ever, detection of anti-CCP in patients with active pulmonary tuberculosis (TB) has recently been rep
32 hroughout the United States for all cases of active pulmonary tuberculosis (TB) to identify secondary
33                                              Active pulmonary tuberculosis was diagnosed in the Unite
34  a 6-month rifampicin-containing regimen for active pulmonary tuberculosis, were randomly assigned 1

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。